A great deal in the legislative activity has stemmed from Purdue Pharma's decision in 2011 to begin a modification of OxyContin's composition to really make it more difficult to crush for snorting or injecting. The new formulation, OxyNeo, is intended to become preventive With this regard and keep its effectiveness for a painkiller. Due to the fact